Shinichiro Nakajima
Shinichiro Nakajima
Unknown affiliation
Verified email at
Cited by
Cited by
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
The potential role of dopamine D3 receptor neurotransmission in cognition
S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ...
European Neuropsychopharmacology 23 (8), 799-813, 2013
Glutamate-mediated excitotoxicity in schizophrenia: a review
E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ...
European Neuropsychopharmacology 24 (10), 1591-1605, 2014
Kynurenic acid in schizophrenia: a systematic review and meta-analysis
E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ...
Schizophrenia bulletin 43 (4), 764-777, 2017
Kynurenine pathway in depression: a systematic review and meta-analysis
K Ogyu, K Kubo, Y Noda, Y Iwata, S Tsugawa, Y Omura, M Wada, ...
Neuroscience & Biobehavioral Reviews 90, 16-25, 2018
Accelerating response to antidepressant treatment in depression: a review and clinical suggestions
S Nakajima, T Suzuki, K Watanabe, H Kashima, H Uchida
Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (2), 259-264, 2010
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
Y Iwata, S Nakajima, T Suzuki, RSE Keefe, E Plitman, JK Chung, ...
Molecular psychiatry 20 (10), 1151-1160, 2015
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
S Moriguchi, A Takamiya, Y Noda, N Horita, M Wada, S Tsugawa, ...
Molecular psychiatry 24 (7), 952-964, 2019
Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia
S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ...
Schizophrenia research 164 (1-3), 164-175, 2015
The evolution of antipsychotic switch and polypharmacy in natural practice—a longitudinal perspective
C Tsutsumi, H Uchida, T Suzuki, K Watanabe, H Takeuchi, S Nakajima, ...
Schizophrenia research 130 (1-3), 40-46, 2011
Psychosis in frontotemporal dementia
S Shinagawa, S Nakajima, E Plitman, A Graff-Guerrero, M Mimura, ...
Journal of Alzheimer's disease 42 (2), 485-499, 2014
Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study
A Graff-Guerrero, TK Rajji, BH Mulsant, S Nakajima, F Caravaggio, ...
JAMA psychiatry 72 (9), 927-934, 2015
Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey
H Tani, H Uchida, T Suzuki, Y Shibuya, H Shimanuki, K Watanabe, R Den, ...
BMC Oral Health 12 (1), 1-6, 2012
Augmentation of atypical antipsychotics with valproic acid. An open‐label study for most difficult patients with schizophrenia
T Suzuki, H Uchida, H Takeuchi, S Nakajima, K Nomura, A Tanabe, ...
Human Psychopharmacology: Clinical and Experimental 24 (8), 628-638, 2009
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open‐label trial of olanzapine plus risperidone for those who failed to …
T Suzuki, H Uchida, K Watanabe, S Nakajima, K Nomura, H Takeuchi, ...
Human Psychopharmacology: Clinical and Experimental 23 (6), 455-463, 2008
Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans
F Caravaggio, C Borlido, M Hahn, Z Feng, G Fervaha, P Gerretsen, ...
International Journal of Neuropsychopharmacology 18 (7), 2015
Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index
F Caravaggio, S Raitsin, P Gerretsen, S Nakajima, A Wilson, ...
Biological psychiatry 77 (2), 196-202, 2015
Lifetime history of depression predicts increased amyloid-β accumulation in patients with mild cognitive impairment
JK Chung, E Plitman, S Nakajima, TW Chow, MM Chakravarty, ...
Journal of Alzheimer's Disease 45 (3), 907-919, 2015
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial
S Nakajima, H Uchida, T Suzuki, K Watanabe, J Hirano, T Yagihashi, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (8), 1983-1989, 2011
Gut microbiota and major depressive disorder: A systematic review and meta-analysis
K Sanada, S Nakajima, S Kurokawa, A Barceló-Soler, D Ikuse, A Hirata, ...
Journal of affective disorders 266, 1-13, 2020
The system can't perform the operation now. Try again later.
Articles 1–20